“Activity levels continued to increase through the second quarter of fiscal 2026 with revenue reaching $244.1 million, a new ...
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a ...
UNITED LITHIUM CORP. (“United” or the “Company”) (CSE: ULTH; OTCQX: ULTHF; FWB: 0UL) is pleased to announce that, further to its ...
The Yomiuri ShimbunA panel of academics comprising, from left, Eijiro Mizutani, Hidemi Suzuki, Yuya Shibuya and moderator ...
Perimeter Solutions, Inc. (NYSE: PRM) ('Perimeter,” 'Perimeter Solutions,” or the 'Company”), today announced that it has entered into a definitive agreement to acquire Medical Manufacturing ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation BOSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Carrick Therapeutics Inc., an ...
Senate screening session for ambassadorial nominees took an unexpected turn on Wednesday when one of President Bola Tinubu’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback